Close
Price range: $149.25 through $209.50
AVAILABILITY: IN STOCK
This product is intended for laboratory research purposes only. It is not intended for human or veterinary use, diagnosis, prevention, or treatment of any disease.
GLP 3 is a research peptide commonly associated with studies involving multi-receptor incretin signaling and metabolic pathway models. It is frequently referenced in laboratory research connected to GLP-1, GIP, and glucagon receptor activity, as well as glucose-related signaling, energy-regulation mechanisms, and peptide receptor behavior.
In research settings, GLP 3 is used to evaluate pathway interactions, receptor-response models, and molecular signaling activity connected to metabolic regulation. Its research relevance is centered on how multiple incretin-related pathways may be studied within controlled laboratory models.
All products are manufactured in ISO-certified facilities and meet strict quality standards.
Product Name: GLP 3 Research Peptide
Size: 10 mg / 15 mg / 20 mg
Format: Lyophilized powder
Category: Metabolic Pathway Research
Intended Use: For Laboratory Research Only
Testing: Third-Party Tested
Storage: Store according to label and COA guidance
Returns: Refer to return policy
Referenced in research models involving GLP-1, GIP, and glucagon receptor pathway activity.
Studied in laboratory models related to glucose-associated signaling, energy regulation, and metabolic pathway interaction.
Used in research involving receptor response, molecular signaling, and peptide-related biological mechanisms.
Access the Certificate of Analysis for this product.
Sequence:
Molecular Formula: C221H342N46O68
Molecular Weight: 4731.33 g/mol
Appearance: Lyophilized powder
Purity: Refer to COA
Solubility: Research solvent dependent INFORMATION
Source: Synthetic Peptide
This product is intended exclusively for laboratory research purposes. It is not intended for human or veterinary use, safety, or diagnostics.
GLP 3 is a research peptide name used by MYOS Peptides for a retatrutide-based research compound. It is associated with laboratory research involving multi-receptor incretin signaling, including GLP-1, GIP, and glucagon receptor pathway activity.
GLP 3 is studied because of its connection to multiple metabolic signaling pathways. Research interest focuses on how GLP-1, GIP, and glucagon receptor activity may interact within controlled laboratory models related to glucose signaling, energy regulation, and peptide receptor response.
Published research has examined retatrutide-related compounds for their activity across GLP-1, GIP, and glucagon receptor pathways. These studies have reported measurable effects on metabolic signaling models, receptor activity, and energy-regulation pathways in controlled research settings.
GLP 3 is commonly associated with research on multi-receptor incretin signaling, metabolic pathway models, glucose-related mechanisms, peptide receptor activity, and molecular signaling related to metabolic regulation.
Learn the basic structure, research context, and laboratory relevance of peptides in modern scientific studies. Button:
Review the research context, receptor pathway activity, and laboratory relevance of GLP 3 as a retatrutide-based research peptide.
